FA
UTHR icon

FDx Advisors’s United Therapeutics UTHR Stock Holding History

FDx Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,348
Closed -$489K – 1101
2018
Q1 		$489K Buy
4,348
+3
+0.1% +$381 0.01% 781
2017
Q4 		$643K Sell
4,345
-363
-8% -$46.1K 0.02% 701
2017
Q3 		$552K Sell
4,708
-168
-3% -$21.5K 0.02% 760
2017
Q2 		$633K Sell
4,876
-538
-10% -$67.1K 0.02% 684
2017
Q1 		$733K Sell
5,414
-572
-10% -$86.7K 0.02% 633
2016
Q4 		$859K Buy
5,986
+52
+0.9% +$6.64K 0.02% 572
2016
Q3 		$701K Buy
5,934
+1,026
+21% +$123K 0.03% 503
2016
Q2 		$520K Sell
4,908
-57
-1% -$6.36K 0.02% 581
2016
Q1 		$553K Buy
4,965
+1,048
+27% +$133K 0.03% 547
2015
Q4 		$613K Buy
3,917
+224
+6% +$32.6K 0.03% 495
2015
Q3 		$485K Buy
3,693
+48
+1% +$7.7K 0.04% 455
2015
Q2 		$626K Buy
3,645
+245
+7% +$44.1K 0.03% 498
2015
Q1 		$579K Sell
3,400
-1,615
-32% -$246K 0.01% 870
2014
Q4 		$649K Sell
5,015
-3,112
-38% -$401K 0.04% 454
2014
Q3 		$1.05M Buy
8,127
+442
+6% +$45.6K 0.07% 317
2014
Q2 		$680K Buy
7,685
+1,944
+34% +$187K 0.04% 471
2014
Q1 		$540K Buy
+5,741
New +$587K 0.05% 418
2013
Q4 		– Sell
-3,600
Closed -$284K – 670
2013
Q3 		$284K Buy
3,600
+118
+3% +$8.63K 0.03% 459
2013
Q2 		$229K Buy
+3,482
New +$224K 0.03% 450

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FDx Advisors's UTHR Position: Q2 2018 in Review

FDx Advisors sold out of United Therapeutics (UTHR) in Q2 2018, closing a stake of 4,348 shares — an estimated $489K sold.

FDx Advisors first reported a position in UTHR in Q2 2013 and held it in 19 quarters. The position peaked at $1.05M in Q3 2014. 374 funds tracked by Wall St. Rank hold UTHR as of Q2 2018.

  • FDx Advisors reported no remaining United Therapeutics position as of Q2 2018 after selling out during the quarter.
  • FDx Advisors sold 4,348 United Therapeutics shares in Q2 2018, an estimated $489K.
  • FDx Advisors first reported a position in United Therapeutics in Q2 2013 and held it in 19 quarters.
  • FDx Advisors's United Therapeutics position peaked at $1.05M in Q3 2014.
  • 374 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2018.

Based on FDx Advisors's 13F filing for Q2 2018, filed 8 Aug 2018.